# Insys Therapeutics, Inc. — Form D

Insys Therapeutics, Inc. of PHOENIX, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-08. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-04-08
- Form: D
- Accession: 0001516479-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 9
- Date of first sale: 2011-03-28
- Revenue range: No Revenues
- SEC file number: 021-158053

## Issuer

- Name: Insys Therapeutics, Inc.
- CIK: 0001516479
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 10220 SOUTH 51ST STREET, PHOENIX, AZ, 85044
- Phone: 602-910-2617

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Michael Babich | Director | Phoenix, AZ |
| Patrick Fourteau | Director | New Haven, CT |
| John Kapoor | Director | Phoenix, AZ |
| Pierre Lapalme | Director | Verdun, A8 |
| Richard Mallery | Director | Phoenix, AZ |
| Steven Meyer | Director | Oak Brook, IL |
| Brian Tambi | Director | Lake Forrest, IL |
| Michael Babich | Executive Officer | Phoenix, AZ |
| Larry Dillaha | Executive Officer | San Diego, CA |
| Martin McCarthy | Executive Officer | Phoenix, AZ |
| Daniel Von Hoff | Executive Officer | Scottsdale, AZ |

## More

- [CIK 1516479 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1516479&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001516479-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.